Blockade of Inflammatory Markers Attenuates Cardiac Remodeling and Fibrosis in Rats with Supravalvular Aortic Stenosis
Open Access
- 5 December 2023
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 11 (12) , 3219
Abstract
Since cardiac inflammation has been considered an important mechanism involved in heart failure, an anti-inflammatory treatment could control cardiac inflammation and mitigate the worsening of cardiac remodeling. This study evaluated the effects of dexamethasone (DEX) and ramipril treatment on inflammation and cardiac fibrosis in an experimental model of heart failure induced by supravalvular aortic stenosis. Wistar rats (21d) were submitted to an aortic stenosis (AS) protocol. After 21 weeks, an echocardiogram and a maximal exercise test were performed, and after 24 weeks, rats were treated with DEX, ramipril or saline for 14d. The left ventricle (LV) was removed for histological and inflammatory marker analyses. The AS group showed exercise intolerance (−32% vs. Sham), higher relative wall thickness (+63%), collagen deposition and capillary rarefaction, followed by cardiac disfunction. Both treatments were effective in reducing cardiac inflammation, but only DEX attenuated the increased relative wall thickness (−17%) and only ramipril reduced LV fibrosis. In conclusion, both DEX and ramipril decreased cardiac inflammatory markers, which probably contributed to the reduced cardiac fibrosis and relative wall thickness; however, treated AS rats did not show any improvement in cardiac function. Despite the complex pharmacological treatment of heart failure, treatment with an anti-inflammatory could delay the patient’s poor prognosis.Keywords
Funding Information
- São Paulo Research Foundation (#2015/03965-2, #2018/00567-4, #2019/25603-6, #311071/2020-1, #307280/2022-5, #303986/2021-2, 001, #88882.426908/2019-01, #88887.634304/2021-00, #88887.634301/2021-00, #88882.426901/2019-01)
- National Council for Scientific and Technological Development (CNPq) (#2015/03965-2, #2018/00567-4, #2019/25603-6, #311071/2020-1, #307280/2022-5, #303986/2021-2, 001, #88882.426908/2019-01, #88887.634304/2021-00, #88887.634301/2021-00, #88882.426901/2019-01)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (#2015/03965-2, #2018/00567-4, #2019/25603-6, #311071/2020-1, #307280/2022-5, #303986/2021-2, 001, #88882.426908/2019-01, #88887.634304/2021-00, #88887.634301/2021-00, #88882.426901/2019-01)
- Coordination for the Improvement of Higher Education Personnel (#2015/03965-2, #2018/00567-4, #2019/25603-6, #311071/2020-1, #307280/2022-5, #303986/2021-2, 001, #88882.426908/2019-01, #88887.634304/2021-00, #88887.634301/2021-00, #88882.426901/2019-01)
This publication has 59 references indexed in Scilit:
- PKCβII inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responsesJournal of Cellular and Molecular Medicine, 2011
- Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection FractionCirculation: Heart Failure, 2011
- Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategiesPharmacology & Therapeutics, 2010
- A new regulation of IL-6 production in adult cardiomyocytes by β-adrenergic and IL-1β receptors and induction of cellular hypertrophy by IL-6 trans-signallingCellular Signalling, 2010
- HFSA 2010 Comprehensive Heart Failure Practice GuidelineJournal of Cardiac Failure, 2010
- Remodelamento cardíaco: análise seriada e índices de detecção precoce de disfunção ventricularArquivos Brasileiros de Cardiologia, 2010
- Improvement of chronic heart failure by dexamethasone is not associated with downregulation of leptin in ratsActa Pharmacologica Sinica, 2007
- Efeitos da inibição prolongada da enzima de conversão da angiotensina sobre as características morfológicas e funcionais da hipertrofia ventricular esquerda em ratos com sobrecarga pressórica persistenteArquivos Brasileiros de Cardiologia, 2005
- Cardiac Angiotensin II Participates in Coronary Microvessel Inflammation of Unstable Angina and Strengthens the Immunomediated ComponentCirculation Research, 2004
- TNF and congestive heart failure: therapeutic possibilitiesExpert Opinion on Therapeutic Targets, 2004